RCTs needed for stem cell therapy in OA

The government should step up and fund randomised trials into the effectiveness of controversial therapies like stem cell therapy for osteoarthritis, an orthopaedic surgeon says.

Despite a lack of evidence many patients with knee osteoarthritis are paying thousands of dollars for a treatment that has no evidence of benefit and could potentially harm.

“Every second patient with knee osteoarthritis comes in asking about stem cells,” said Professor Ian Harris from the UNSW who was speaking at the conference on the efficacy (or lack of) effectiveness of injections and other therapies commonly used in